Extended Data Fig. 1: Neutralization of Omicron BA.1 SARS-CoV-2 Variant by Antivirals. | Nature Biotechnology

Extended Data Fig. 1: Neutralization of Omicron BA.1 SARS-CoV-2 Variant by Antivirals.

From: The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Extended Data Fig. 1: Neutralization of Omicron BA.1 SARS-CoV-2 Variant by Antivirals.

Titration curves (mean ± SEM) and IC50 values (mean ± CI at 95%) for VSV-pseudotype neutralization assays with wild-type and two different Omicron BA.1 variant spike proteins containing either an arginine or a lysine in position Q493. Ensovibep was tested together with a panel of clinically validated monoclonal antibodies. The table provides the numeric IC50 values as well as the fold change towards the wild-type values.

Back to article page